Effectiveness, safety, and costs of thromboprophylaxis with enoxaparin or unfractionated heparin in inpatients with obesity

Effectiveness, safety, and costs of thromboprophylaxis with enoxaparin or unfractionated heparin in inpatients with obesity

BackgroundObesity is a frequent and significant risk factor for venous thromboembolism (VTE) among hospitalized adults. Pharmacologic thromboprophylaxis can help prevent VTE, but real-world effectiveness, safety, and costs among inpatients with obesity are unknown.ObjectiveThis study aims to compare...

Full description

Bibliographic Details
Main Authors: Alpesh Amin, Alex Kartashov, Wilson Ngai, Kevin Steele, Ning Rosenthal
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-06-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
thromboprophylaxis
obesity
medical inpatients
enoxaparin
unfractionated heparin
cost analyses
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2023.1163684/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2023.1163684/full

Similar Items